Literature DB >> 33037877

Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs.

Gregory D Kirk1,2, Jacqueline Astemborski1, Shruti H Mehta1, Kristen D Ritter3, Gregory M Laird3, Rebeka Bordi4, Rafick Sekaly4, Janet D Siliciano2, Robert F Siliciano2,5.   

Abstract

The latent reservoir for human immunodeficiency virus type 1 (HIV-1) in CD4+ T cells is a major barrier to cure. HIV-1-infected persons who inject drugs (PWID) often struggle to maintain suppression of viremia and experience nonstructured treatment interruptions (NTIs). The effects of injecting drugs or NTIs on the reservoir are unclear. Using the intact proviral DNA assay, we found no apparent effect of heroin or cocaine use on reservoir size. However, we found significantly larger reservoirs in those with frequent NTIs or a shorter interval from last detectable HIV RNA measurement. These results have important implications for inclusion of PWID in HIV-1 cure studies.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ART; HIV-1 latent reservoir; HIV-1 viral suppression; NTI; PWID; antiretroviral therapy; nonstructured treatment interruption; people who inject drugs

Mesh:

Substances:

Year:  2021        PMID: 33037877      PMCID: PMC8176633          DOI: 10.1093/infdis/jiaa634

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

3.  Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA.

Authors:  Francesco R Simonetti; Jennifer A White; Camille Tumiotto; Kristen D Ritter; Mian Cai; Rajesh T Gandhi; Steven G Deeks; Bonnie J Howell; Luis J Montaner; Joel N Blankson; Albine Martin; Gregory M Laird; Robert F Siliciano; John W Mellors; Janet D Siliciano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-20       Impact factor: 11.205

4.  Nonstructured treatment interruptions among injection drug users in Baltimore, MD.

Authors:  Ravi Kavasery; Noya Galai; Jacquie Astemborski; Gregory M Lucas; David D Celentano; Gregory D Kirk; Shruti H Mehta
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

5.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

6.  Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation.

Authors:  Eileen P Scully; Monica Gandhi; Rowena Johnston; Rebecca Hoh; Ainsley Lockhart; Curtis Dobrowolski; Amélie Pagliuzza; Jeffrey M Milush; Christopher A Baker; Valerie Girling; Arlvin Ellefson; Robert Gorelick; Jeffrey Lifson; Marcus Altfeld; Galit Alter; Marcelle Cedars; Ajantha Solomon; Sharon R Lewin; Jonathan Karn; Nicolas Chomont; Peter Bacchetti; Steven G Deeks
Journal:  J Infect Dis       Date:  2019-03-15       Impact factor: 5.226

7.  Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.

Authors:  Megan L Salter; Bryan Lau; Shruti H Mehta; Vivian F Go; Sean Leng; Gregory D Kirk
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-15       Impact factor: 3.731

8.  Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda.

Authors:  Jessica L Prodger; Adam A Capoferri; Katherine Yu; Jun Lai; Steven J Reynolds; Jingo Kasule; Taddeo Kityamuweesi; Paul Buule; David Serwadda; Kyungyoon J Kwon; Katherine Schlusser; Craig Martens; Eileen Scully; Yun-Hee Choi; Andrew D Redd; Thomas C Quinn
Journal:  JCI Insight       Date:  2020-07-23

9.  The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.

Authors:  Ole S Søgaard; Mette E Graversen; Steffen Leth; Rikke Olesen; Christel R Brinkmann; Sara K Nissen; Anne Sofie Kjaer; Mariane H Schleimann; Paul W Denton; William J Hey-Cunningham; Kersten K Koelsch; Giuseppe Pantaleo; Kim Krogsgaard; Maja Sommerfelt; Remi Fromentin; Nicolas Chomont; Thomas A Rasmussen; Lars Østergaard; Martin Tolstrup
Journal:  PLoS Pathog       Date:  2015-09-17       Impact factor: 6.823

10.  Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics.

Authors:  Nina N Hosmane; Kyungyoon J Kwon; Katherine M Bruner; Adam A Capoferri; Subul Beg; Daniel I S Rosenbloom; Brandon F Keele; Ya-Chi Ho; Janet D Siliciano; Robert F Siliciano
Journal:  J Exp Med       Date:  2017-03-24       Impact factor: 14.307

View more
  3 in total

Review 1.  Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection.

Authors:  Ruojing Bai; Shiyun Lv; Hao Wu; Lili Dai
Journal:  Dis Markers       Date:  2022-05-31       Impact factor: 3.464

2.  Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence.

Authors:  Alysse Schultheis; Mark Sanchez; Savannah Pedersen; Tassos Kyriakides; Ya-Chi Ho; Yuval Kluger; Sandra A Springer
Journal:  Contemp Clin Trials Commun       Date:  2021-11-11

3.  Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir.

Authors:  Taina T Immonen; Christine M Fennessey; Leslie Lipkey; Abigail Thorpe; Gregory Q Del Prete; Jeffrey D Lifson; Miles P Davenport; Brandon F Keele
Journal:  PLoS Pathog       Date:  2021-06-18       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.